Shares of McKesson Co. (NYSE:MCK) have received an average recommendation of “Hold” from the twenty brokerages that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $174.85.
MCK has been the subject of several research reports. Needham & Company LLC reiterated a “buy” rating and set a $173.00 price target (down from $178.00) on shares of McKesson in a research report on Wednesday, November 1st. ValuEngine cut McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Jefferies Group set a $165.00 price target on McKesson and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Evercore ISI started coverage on McKesson in a research note on Thursday, January 4th. They set an “outperform” rating and a $179.00 price objective on the stock. Finally, Zacks Investment Research raised McKesson from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a research note on Tuesday, December 26th.
In other news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.20% of the company’s stock.
Shares of McKesson (MCK) traded down $1.42 on Friday, hitting $170.36. The company had a trading volume of 2,399,922 shares, compared to its average volume of 1,560,000. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.05 and a quick ratio of 0.61. McKesson has a 52-week low of $133.82 and a 52-week high of $173.84. The stock has a market capitalization of $35,520.00, a PE ratio of 8.07, a price-to-earnings-growth ratio of 1.75 and a beta of 1.23.
McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, October 26th. The company reported $3.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.78 by $0.50. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.69 billion. During the same period in the previous year, the business earned $2.94 earnings per share. The firm’s revenue for the quarter was up 4.2% on a year-over-year basis. sell-side analysts predict that McKesson will post 12.26 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date was Thursday, November 30th. McKesson’s dividend payout ratio (DPR) is currently 6.44%.
TRADEMARK VIOLATION WARNING: “McKesson Co. (MCK) Receives Average Recommendation of “Hold” from Analysts” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2018/01/20/mckesson-co-mck-receives-average-recommendation-of-hold-from-analysts.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.